Correlation Between Recursion Pharmaceuticals and BARCLAYS
Specify exactly 2 symbols:
By analyzing existing cross correlation between Recursion Pharmaceuticals and BARCLAYS PLC 365, you can compare the effects of market volatilities on Recursion Pharmaceuticals and BARCLAYS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of BARCLAYS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and BARCLAYS.
Diversification Opportunities for Recursion Pharmaceuticals and BARCLAYS
-0.27 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Recursion and BARCLAYS is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and BARCLAYS PLC 365 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BARCLAYS PLC 365 and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with BARCLAYS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BARCLAYS PLC 365 has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and BARCLAYS go up and down completely randomly.
Pair Corralation between Recursion Pharmaceuticals and BARCLAYS
Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to generate 6.32 times more return on investment than BARCLAYS. However, Recursion Pharmaceuticals is 6.32 times more volatile than BARCLAYS PLC 365. It trades about 0.1 of its potential returns per unit of risk. BARCLAYS PLC 365 is currently generating about -0.19 per unit of risk. If you would invest 603.00 in Recursion Pharmaceuticals on October 21, 2024 and sell it today you would earn a total of 50.00 from holding Recursion Pharmaceuticals or generate 8.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Recursion Pharmaceuticals vs. BARCLAYS PLC 365
Performance |
| Timeline |
| Recursion Pharmaceuticals |
| BARCLAYS PLC 365 |
Recursion Pharmaceuticals and BARCLAYS Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Recursion Pharmaceuticals and BARCLAYS
The main advantage of trading using opposite Recursion Pharmaceuticals and BARCLAYS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, BARCLAYS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BARCLAYS will offset losses from the drop in BARCLAYS's long position.| Recursion Pharmaceuticals vs. Absci Corp | Recursion Pharmaceuticals vs. Affimed NV | Recursion Pharmaceuticals vs. Sana Biotechnology | Recursion Pharmaceuticals vs. Relay Therapeutics |
| BARCLAYS vs. Envista Holdings Corp | BARCLAYS vs. Arm Holdings plc | BARCLAYS vs. Skechers USA | BARCLAYS vs. JBG SMITH Properties |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |